He Shao-Heng, Xie Hua, He Yong-Song
Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031, Guangdong Province, China.
World J Gastroenterol. 2004 Feb 1;10(3):319-22. doi: 10.3748/wjg.v10.i3.319.
To investigate the tryptase and histamine release ability of human colon mast cells upon IgE dependent or independent activation and the potential mechanisms.
Enzymatically dispersed cells from human colons were challenged with anti-IgE or calcium ionophore A23187, and the cell supernatants after challenge were collected. Both concentration dependent and time course studies with anti-IgE or calcium ionophore A23187 were performed. Tryptase release was determined with a sandwich ELISA procedure and histamine release was measured using a glass fibre-based fluorometric assay.
Both anti-IgE and calcium ionophore were able to induce dose dependent release of histamine from colon mast cells with up to approximately 60% and 25% net histamine release being achieved with 1 microg/mL calcium ionophore and 10 microg/mL anti-IgE, respectively. Dose dependent release of tryptase was also observed with up to approximately 19 ng/mL and 21 ng/mL release of tryptase being achieved with 10 microg/mL anti-IgE and 1 microg/mL calcium ionophore, respectively. Time course study revealed that both tryptase and histamine release from colon mast cells stimulated by anti-IgE initiated within 10 sec and reached their maximum release at 6 min following challenge. Pretreatment of cells with metabolic inhibitors abolished the actions of anti-IgE as well as calcium ionophore. Tryptase and histamine release, particularly that induced by calcium ionophore was inhibited by pretreatment of cells with pertussis toxin.
Both anti-IgE and calcium ionophore are able to induce significant release of tryptase and histamine from colon mast cells, indicating that this cell type is likely to contribute to the pathogenesis of colitis and other mast cell associated intestinal diseases.
研究人结肠肥大细胞在IgE依赖或非依赖激活时的类胰蛋白酶和组胺释放能力及其潜在机制。
用抗IgE或钙离子载体A23187刺激人结肠酶解分散的细胞,收集刺激后的细胞上清液。进行了抗IgE或钙离子载体A23187的浓度依赖性和时间进程研究。用夹心酶联免疫吸附测定法测定类胰蛋白酶释放,用基于玻璃纤维的荧光测定法测量组胺释放。
抗IgE和钙离子载体均能诱导结肠肥大细胞组胺剂量依赖性释放,1μg/mL钙离子载体和10μg/mL抗IgE分别使组胺净释放量达到约60%和25%。也观察到类胰蛋白酶的剂量依赖性释放,10μg/mL抗IgE和1μg/mL钙离子载体分别使类胰蛋白酶释放量达到约19 ng/mL和21 ng/mL。时间进程研究显示,抗IgE刺激的结肠肥大细胞中类胰蛋白酶和组胺释放在刺激后10秒内开始,并在6分钟时达到最大释放量。用代谢抑制剂预处理细胞可消除抗IgE和钙离子载体的作用。用百日咳毒素预处理细胞可抑制类胰蛋白酶和组胺释放,尤其是钙离子载体诱导的释放。
抗IgE和钙离子载体均能诱导结肠肥大细胞显著释放类胰蛋白酶和组胺,表明这种细胞类型可能在结肠炎和其他肥大细胞相关肠道疾病的发病机制中起作用。